Navigation Links
Global Vision Brings Industry Leading Proofreading Solutions to FachPack
Date:9/20/2013

Montreal, Canada (PRWEB) September 20, 2013

Global Vision, the industry leader in the development of innovative proofreading technologies, today announced its participation at Fachpack – Booth 7-125 September 24 – 26, NürnbergMesse, Nürnberg, Germany.

Latest Innovative Proofreading Solutions
At this year's event, Global Vision is set to showcase its extensive line of award-winning packaging inspection technologies, including the latest release of its print, text and artwork inspection software and hardware - Digital-Page, ScanTVS and Docu-Proof.

Digital-Page is a powerful solution for automatically comparing graphic files in seconds instead of hours.
Digital-Page can quickly detect and identify missing text and graphics, incorrect fonts and text size, as well as broken type and color deviations.

ScanTVS is an innovative proofreading system for complete inspection of proofs, labels, cartons and nested press sheets for both printed items and electronic files.

For wet ink inspections, Scan Wet-ink enables printers to inspect wet ink press sheets without the risk of cross contamination or smudging.

Docu-Proof enables users to quickly compare text in virtually any language, including unlike files (Word to PDF).

QCanywhere
The company will also spotlight QCanywhere the worlds first cloud-based document, print and artwork inspection solutions.

Join the QCanywhere Revolution.
Global Vision is offering a free 15 day trial of QCanywhere to all attendees of Fachpack.
Please visit http://www.QCanywhere.com; use promo code: QCfachpack.

The StandardPractice
Global Vision will be offering free information seminars on the StandardPractice, the industries first set of guidelines outlining the issues, risks, solutions and tools involved in the creation of digital files.

When: Wednesday September 25th, 2013 – Lissabon Room, Birmingham England.
A full agenda is available at the Global Vision Booth 7-125

Commenting on Global Vision’s participation at FachPack, Reuben Malz, President of Global Vision and QCanywhere said: “To help ensure the protection of your brand packaging, proofreading is critical to any companies packaging workflow, and FachPack is a perfect venue to showcase our latest ground-breaking technologies to the European market.”

Visit Us:
Pharma Packaging & Labelling Europe Conference: September 25th – 26th, 2013, Steigenberger Airport Hotel, Amsterdam, Amsterdam, Netherlands
Empack: October 2nd – 3rd, 2013, Brussels Expo, Brussels, Belgium, Booth 9.169

About Global Vision
Global Vision is the world leader in the design and delivery of automated proofreading solutions. Its complete suite of advanced solutions featuring text-based, pixel-based and Braille inspection technologies are designed to eliminate printed artwork, text verification, and text comparison related errors, providing end-to-end security at every stage of the workflow process.

Global Vision solutions are widely interoperable and have received commercial endorsement from the world’s leading Pharmaceutical, Consumer Packaged Goods (CPG), and Artwork Management companies.

Headquartered in Montreal, Canada, Global Vision has worldwide representation. For more information, please visit http://www.GlobalVisionInc.com.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11141375.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Canada should play a role in addressing the global cancer epidemic
3. Global cardiology leaders meet in Dubai
4. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
5. International breast health global summit will focus on supportive care and quality of life
6. Scientists rewrite rulebook on breast cancer in landmark global study
7. Global CVD leaders call the world to action - 25 by 2025 - from the World Congress of Cardiology
8. Centre for Global Non-Communicable Diseases launched to tackle killer diseases
9. UCLA researchers combat global disease with a cell phone, Google Maps and a lot of ingenuity
10. New study identifies how information technology is used to solve global health challenges
11. New global report says US lags behind 130 other nations in preterm birth rate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... Texas (PRWEB) , ... August 19, 2017 , ... ... with contemporary illustrations of breastfeeding mothers. These illustrations show the diversity ... available in prints in a wide range of sizes. These illustrations are also ...
(Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions for ... agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
(Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
Breaking Medicine Technology: